Evidence map›Paper›PMID 25999584›Full record

ArticleG3 (Bethesda, Md.)2015

Genome-Wide Analysis of Drosophila RBf2 Protein Highlights the Diversity of RB Family Targets and Possible Role in Regulation of Ribosome Biosynthesis.

Yiliang Wei, Shamba S Mondal, Rima Mouawad, Bartek Wilczyński, R William Henry, David N Arnosti

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Soft repression: Subtle transcriptional regulation with global impact.BioEssays : news and reviews in molecular, cellular and developmental biology · 2021
    Article
  4. Selective repression of the Drosophila cyclin B promoter by retinoblastoma and E2F proteins.Biochimica et biophysica acta. Gene regulatory mechanisms · 2020
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Yiliang WeiDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824-1319.
Shamba S MondalLaboratory of Molecular Neurobiology and Laboratory of Bioinformatics, Nencki Institute of Experimental Biology, Pasteura 3, 02-093 Warsaw, Poland.
Rima MouawadCell and Molecular Biology Program, Michigan State University, East Lansing, Michigan 48824-1319.
Bartek WilczyńskiInstitute of Informatics, University of Warsaw, Banacha 2, 02-097 Warsaw, Poland.
R William HenryDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824-1319.
David N ArnostiDepartment of Biochemistry and Molecular Biology, Michigan State University, East Lansing, Michigan 48824-1319 arnosti@msu.edu.
Michigan State University · USInstytut Biologii Doświadczalnej im. Marcelego Nenckiego · PLUniversity of Warsaw · PL

Funding

MOLECULAR ANALYSIS OF TRANSCRIPTIONAL REPRESSIONR01GM056976 · NIGMS · MICHIGAN STATE UNIVERSITY · PI ARNOSTI, DAVID N · 1998 to 2014
$4.7M
Analysis of the COP9 signalosome for Retinoblastoma functionR01GM079098 · NIGMS · MICHIGAN STATE UNIVERSITY · PI ARNOSTI, DAVID N · 2007 to 2010
$1.1M
NIGMS NIH HHS GM056976NIGMS NIH HHS GM79098NIGMS NIH HHS R01 GM056976NIGMS NIH HHS R01 GM079098
6 · The paper itself

Abstract

RBf2 is a recently evolved retinoblastoma family member in Drosophila that differs from RBf1, especially in the C-terminus. To investigate whether the unique features of RBf2 contribute to diverse roles in gene regulation, we performed chromatin immunoprecipitation sequencing for both RBf2 and RBf1 in embryos. A previous model for RB-E2F interactions suggested that RBf1 binds dE2F1 or dE2F2, whereas RBf2 is restricted to binding to dE2F2; however, we found that RBf2 targets approximately twice as many genes as RBf1. Highly enriched among the RBf2 targets were ribosomal protein genes. We tested the functional significance of this finding by assessing RBf activity on ribosomal protein promoters and the endogenous genes. RBf1 and RBf2 significantly repressed expression of some ribosomal protein genes, although not all bound genes showed transcriptional effects. Interestingly, many ribosomal protein genes are similarly targeted in human cells, indicating that these interactions may be relevant for control of ribosome biosynthesis and growth. We carried out bioinformatic analysis to investigate the basis for differential targeting by these two proteins and found that RBf2-specific promoters have distinct sequence motifs, suggesting unique targeting mechanisms. Association of RBf2 with these promoters appears to be independent of dE2F2/dDP, although promoters bound by both RBf1 and RBf2 require dE2F2/dDP. The presence of unique RBf2 targets suggest that evolutionary appearance of this corepressor represents the acquisition of potentially novel roles in gene regulation for the RB family.

Indexed as

GenomeAnimalsChromatin ImmunoprecipitationDNA-Binding ProteinsDrosophilaDrosophila ProteinsE2F2 Transcription FactorEmbryo, NonmammalianEye ProteinsGene Expression RegulationGenes, ReporterPromoter Regions, GeneticProtein BindingRepressor ProteinsRetinoblastoma ProteinRibosomesBEAF-32 protein, DrosophilaDNA-Binding ProteinsDrosophila ProteinsE2f1 protein, DrosophilaE2f2 protein, DrosophilaE2F2 Transcription FactorEye ProteinsRBF2 protein, DrosophilaRbf protein, DrosophilaRepressor ProteinsRetinoblastoma ProteinRNA, Double-StrandedTranscription FactorsDrosophilaRBf1RBf2retinoblastomaribosomal protein gene

Identifiers

PMID25999584
PMCPMC4502384
OpenAlexW2114270664

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.